# Compounded Semaglutide: Is a Prescription Required?

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-14 | Updated: 2026-10-30

Canonical page: https://glpwatchdog.org/research/do-you-need-prescription-compounded-semaglutide

> Yes, but 503A and 503B do not carry the same requirement, and the gap between them is where the no-prescription pitches live. What each route actually asks for.

## Key points

- 503A compounding requires a prescription written for a specific, identified patient.
- 503B outsourcing facilities may also supply on a provider order naming no patient, but that route ends at a clinic, not your door.
- "For research purposes" is the seller's legal position in writing, not a product grade.
- An asynchronous questionnaire can be a legitimate consult; an absent prescriber cannot.

Yes. Every route that can lawfully put compounded semaglutide in your hands runs through a prescriber, and any seller telling you otherwise is describing a transaction that sits outside the pharmacy system rather than a shortcut through it. The more useful question is which route a seller is claiming, because the two federal ones do not carry the same requirement. That gap is where the misleading pitches live.

## The two routes ask for different things

Compounding happens under one of two sections of federal law, and they are not interchangeable ([503A vs 503B compounding pharmacies](https://glpwatchdog.org/research/503a-vs-503b-compounding-pharmacies)). A 503A pharmacy has to be working from a valid prescription written for a specific, identified patient. A 503B outsourcing facility can do that too, but it may also ship against an order from a health-care provider (a hospital, say) that names no individual patient at all.[1]

*What each compounding route requires*

|   | 503A pharmacy | 503B outsourcing facility |
| --- | --- | --- |
| Patient-specific prescription | Required | One of two permitted bases |
| Provider order not naming a patient | Not permitted | Permitted |
| Subject to CGMP manufacturing rules | No | Yes |
| What it means for you as a buyer | A prescriber must have written it for you | Still reaches you through a prescriber |

> **Why the distinction matters to a reader, not just a lawyer.** The 503B provider-order route is real, and a seller can point at it truthfully. But it is how a facility stocks a clinic’s shelf. It does not end with a vial arriving at your door with no clinician involved.

## So what is being sold without one?

Something that is not operating as a pharmacy. The sellers offering semaglutide or tirzepatide with no prescriber in the loop generally label the product as being for research, or as not for human consumption. That wording is not a product grade or a technicality. It is the seller’s legal position, in writing, about what they are handing you.

FDA has acted against companies using exactly those labels on unapproved GLP-1 products, and has said it is aware of counterfeit Ozempic reaching buyers in the United States. Its instruction for anyone purchasing medication online is a single sentence long: use a state-licensed pharmacy.[2]

- **“No prescription needed”** means no clinician is accountable for your dose, your titration, or what happens if it goes wrong. It also means the product is not a GLP-1 drug sold lawfully, because [no GLP-1 drug is available over the counter](https://glpwatchdog.org/research/is-ozempic-available-over-the-counter) in the US.
- **“Research use only”** means the seller has told you in writing that this is not for you to inject, and that statement still stands after you buy.
- **No named dispensing pharmacy** leaves you nothing to look up in a state board register and no one to complain to.
- **A checkout with no intake at all** is a clear warning. A questionnaire that cannot be failed is a problem too, but a different and less obvious one.

## A quick consult is still a consult

Plenty of legitimate telehealth runs on an asynchronous questionnaire rather than a video visit, and that is lawful in most of the country. Check whether a named, licensed prescriber signed off and whether a named pharmacy dispensed; how long it took matters less. Both details should be findable without asking. Where they are not, we say so in the [provider register](https://glpwatchdog.org/reviews).

Sellers answer that in very different ways. [JM Integrated Health](https://glpwatchdog.org/reviews/jm-integrated-health) is led by a nurse practitioner, John Meyer, who treats patients himself in the eight states it lists. [SurpassMD](https://glpwatchdog.org/reviews/surpassmd) connects patients with an independent medical group, and [VivioMD](https://glpwatchdog.org/reviews/viviomd) says OpenLoop Healthcare Partners clinicians prescribe and that a live provider consult is included. [G-Plans](https://glpwatchdog.org/reviews/g-plans), a meal-plan subscription, also has OpenLoop’s medical group write its prescriptions, and shows no price until after the health intake. VivioMD also received an FDA warning letter over website labels that implied it compounds the drugs itself, a reminder that the seller and the pharmacy are usually different businesses.

> **The shortage answer has expired.** If a seller explains its prescription-free model by pointing at the GLP-1 shortages, that reasoning ran out in 2025, and it never licensed selling without a prescriber in the first place. Our [explainer on which GLP-1s can still be compounded](https://glpwatchdog.org/research/which-glp1-can-be-compounded) sets out what changed and when.[3]

## What to ask, in order

1. **Who is the prescriber, and are they licensed in my state?** A name you can check, not “our medical team”.
2. **Which pharmacy dispenses it?** An unnamed “partner network” does not answer the question.
3. **Is this the approved product or a compounded one?** If compounded, on what basis now that the shortages have closed?
4. **What happens if I have a reaction?** A seller with no clinician cannot answer it.

Some services put the prescriber inside a program you may already have. [Teladoc Health](https://glpwatchdog.org/reviews/teladoc-health) prescribes GLP-1s only to members whose employer or health plan offers an eligible program, [Enara Health](https://glpwatchdog.org/reviews/enara-health) runs an insurance-billed obesity medicine program through partner clinics in five states, and [T2D.com](https://glpwatchdog.org/reviews/t2d) builds its prescriber-included service around type 2 diabetes and prediabetes. At the other end, [OlleveCare](https://glpwatchdog.org/reviews/ollevecare) names no medical director or pharmacy and does not say whether its drugs are compounded, and [Vela Rx](https://glpwatchdog.org/reviews/vela-rx) names neither its medical group nor its pharmacy, so the first two questions above are where to start with either of them.

## Frequently asked questions

### Do I need a prescription for compounded semaglutide?

For anything you can lawfully be dispensed, yes. A 503A pharmacy must compound against a prescription written for you specifically. A 503B outsourcing facility can also supply on a provider order that names no patient, but that route ends at a clinic's shelf rather than at your door, so a prescriber is still between you and the vial.

### Is it illegal for me to buy semaglutide without a prescription?

Enforcement in this area is aimed at sellers rather than buyers, so the practical risk to you is less legal than medical: an unapproved product from an unlicensed source, with no clinician monitoring the dose and no recourse if something is wrong with what is in the vial.

### Does a questionnaire count as a real consultation?

It can. Asynchronous telehealth is lawful in most states and is how a large share of legitimate prescribing happens. What matters is that a licensed prescriber reviewed it and can be named, not whether you spoke to someone by video.

### What about vials labeled “for research purposes”?

That label is the seller's legal position, not a description of quality. FDA has taken action against companies selling unapproved GLP-1 products under exactly that wording. It is not a cheaper version of the same thing.

## References

1. U.S. Food and Drug Administration Human Drug Compounding Laws. FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
2. U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA Drug Safety and Availability. 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
3. U.S. Food and Drug Administration FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize

---

Cite as: GLP Watchdog, Ruth Calder, "Compounded Semaglutide: Is a Prescription Required?", published 2026-08-14, updated 2026-10-30. https://glpwatchdog.org/research/do-you-need-prescription-compounded-semaglutide

Canonical HTML page: https://glpwatchdog.org/research/do-you-need-prescription-compounded-semaglutide

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.